임상시험

A new experimental oral medication called elecoglipron improved blood sugar control and promoted weight loss in adults with type 2 diabetes during a phase 2b trial. Results from the SOLSTICE study were presented at the American Diabetes Association's Scientific Sessions and published in The Lancet.

2026년 06월 04일 AI에 의해 보고됨

A new treatment called Daraxonrasib has shown strong results against advanced pancreatic cancer in a recent clinical trial. The drug targets a genetic mutation long considered impossible to treat effectively.

타케다 제약은 AI 지원 경구 건선 약물 zasocitinib이 후기 단계 시험에서 안전성과 효과를 입증했다고 발표했다. 이 매일 한 번 복용 알약은 중등도에서 중증 플라크 건선 환자의 피부 청결에서 위약 및 기존 치료제 apremilast보다 우수한 성과를 보였다. 승인될 경우 이는 인공지능으로 발견된 최초의 약물 중 하나가 될 것이다.

2025년 12월 03일 AI에 의해 보고됨

An experimental nasal vaccine has for the first time prevented the colonization of whooping cough bacteria in humans, according to a recently published clinical trial. This breakthrough could curb the disease's spread, particularly in a year of record cases in England. The BPZE1 vaccine, developed by ILiAD Biotechnologies, reduced bacterial presence by over 97% compared to placebo.

A combination of enzalutamide and hormone therapy has reduced the risk of death by more than 40% in men with recurring prostate cancer, according to a major clinical trial. The study, involving over 1,000 patients worldwide, was led by researchers at Cedars-Sinai and presented at a medical congress in Berlin. Experts describe the findings as a game changer for treating aggressive cases.

2025년 09월 30일 AI에 의해 보고됨

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.